Angion’s mission is to reduce or eliminate the consequences of renal dysfunction associated with kidney transplant, acute kidney injury and chronic kidney disease.
Here are some helpful links to kidney disease related organizations:
American Society of Transplantation
Kidney Transplant/Dialysis Association
American Transplant Foundation
United Network for Organ Sharing
National Kidney Foundation
American Association of Kidney Patients
National Institute of Diabetes and Digestive and Kidney Diseases
American Kidney Fund
National Organization for Renal Disease
Polycystic Kidney Disease Foundation
A PATIENT Story
"During my childhood, I watched my mother endure two kidney transplants that she needed as a result of her polycystic kidney disease (which I also inherited). Following my first transplant in February 2015, I had complications after 2 ½ months and I had to undergo hemodialysis, awaiting a second transplant. Luckily, 6 months after the first transplant I received my second new kidney. I was blessed enough to receive the gift of life twice!!
"BB3 is a novel drug developed by Angion Biomedica Corp. for renal transplantation. BB3 has the potential to significantly improve function of the transplanted kidney, make the graft last longer and greatly increase the number of transplants being performed.”
- Madhu T., patient